arrow_back Back to App

Cannabinoid Safety and Regulation Act: New Rules for Products and Public Safety

This act establishes federal standards for the safety, labeling, and sale of cannabinoid products to protect public health. It mandates manufacturing and testing requirements, prohibits sales to minors, and funds programs to prevent impaired driving and underage use. This ensures products are safe and properly labeled, while mitigating risks associated with their consumption.
Key points
Sets federal safety and labeling standards for cannabinoid products, including bans on artificially or synthetically derived cannabinoids and mandatory testing.
Prohibits the sale of cannabinoid products to individuals under 21 and imposes civil penalties for violations.
Funds research and educational programs aimed at preventing cannabis-impaired driving and underage cannabis use.
Establishes a registration system for entities involved in manufacturing, packing, or distributing cannabinoid products.
Allows states to enact stricter regulations but prohibits them from banning the transport of compliant products through their territory.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_3474
Sponsor: Sen. Wyden, Ron [D-OR]
Process start date: 2025-12-15
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Cannabinoid Safety and Regulation Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_3474.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-12-15.

What are the main provisions?

Key points include:

  • Sets federal safety and labeling standards for cannabinoid products, including bans on artificially or synthetically derived cannabinoids and mandatory testing.
  • Prohibits the sale of cannabinoid products to individuals under 21 and imposes civil penalties for violations.
  • Funds research and educational programs aimed at preventing cannabis-impaired driving and underage cannabis use.
  • Establishes a registration system for entities involved in manufacturing, packing, or distributing cannabinoid products.
  • Allows states to enact stricter regulations but prohibits them from banning the transport of compliant products through their territory.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Wyden, Ron [D-OR].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-11.

CATEGORIES

Health Courts and Law Transport